Pancreatic Clinical Trials
Delivering quality care through clinical trials
Study Phase: Phase II/III
Condition(s): Metastatic pancreatic cancer, previously untreated
A Randomized, Phase 2/3 Study Comparing BMS-986504 Combined with Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion
ClinicalTrials.gov NCT ID: NCT07076121
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionStudy Phase: Observational - Screening
Condition(s): Pancreatic cyst
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
ClinicalTrials.gov NCT ID: NCT04239573
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionStudy Phase: Phase III - Prevention
Condition(s): Distal Pancreatectomy
A Randomized Phase III Blinded Tral of Lanreotide For The Prevention Of Postoperative Pancreatic Fistula
ClinicalTrials.gov NCT ID: NCT06807437
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionTo inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.